On 18 January, EMA’s Management Board was provided with an update on recent improvements introduced in the Clinical Trials Information System (#CTIS) and progress made for its mandatory use from 31 January 2023.⏰🗓️
🐦🔗: https://n.respublicae.eu/EMA_News/status/1616085679544344576
As of 🗓️31 January 2023, #ClinicalTrial sponsor will have to use the Clinical Trials Information System and follow the same process to apply for the authorisation of a clinical trial in the #EEA.
Learn more from the video 👇
🐦🔗: https://n.respublicae.eu/EMA_News/status/1608770746934874113
Are you a #ClinicalTrial sponsor? As of 🗓️31 January 2023, you will have to use the Clinical Trials Information System and follow the same process to apply for the authorisation of a clinical trial in the #EEA.
Learn more from the video 👇
#EUClinicalTrials
RT @EMA_News: With the #ClinicalTrials Information System, CTIS, sponsors can now apply for authorisations in up to 30 EEA countries through a single application. There is a transition period for this. Find out more about it in this carousel. #EUClinicalTrials
RT @EMA_News: #DYK that today marks the International Clinical Trials Day? An occasion to celebrate the role that #ClinicalTrials play in scientific research, ensuring access to innovative 💊💊.
In 2022, EU is improving the environment for #EUclinicaltrials. See how. #ACTEU #HealthUnion
RT @bfarm_de: BfArM President @Karl_Broich: Our aim is to improve the way #EUclinicaltrials are regulated to better support medical research + innovation. #CTIS is an important step to simplify and expedit the application process. But we want to go further: https://t.co/0p5wgHe2VR #ICTD2022
Clinical trials are a prerequisite for medical progress. They offer patients a chance at early access to innovative therapeutic options as new treatment possibilities are introduced into medical practice. Prof. Karl Broich, President of the BfArM explains why Europe is such an important environment for clinical trials and what changes are necessary with regard to authorisation procedures.
With the #ClinicalTrials Information System, CTIS, sponsors can now apply for authorisations in up to 30 EEA countries through a single application. There is a transition period for this. Find out more about it in this carousel. #EUClinicalTrials
Do you want to understand how the EU is improving the way #EUclinicaltrials are regulated to better support transparency, medical research and innovation?
Watch this video translated in all EU languages! #ClinicalTrials
https://www.youtube.com/playlist?list=PL7K5dNgKnawakh8SgoURKXojuKoyc387Z
#DYK that today marks the International Clinical Trials Day? An occasion to celebrate the role that #ClinicalTrials play in scientific research, ensuring access to innovative 💊💊.
In 2022, EU is improving the environment for #EUclinicaltrials. See how. #ACTEU #HealthUnion
#DYK that today marks the International Clinical Trials Day? An occasion to celebrate the role that #ClinicalTrials play in scientific research, ensuring access to innovative 💊💊. In 2022, EU is improving the environment for #EUclinicaltrials. See how. #ACTEU #HealthUnion
RT @EMA_News: Do you want to understand how the EU is improving the way #EUclinicaltrials are regulated to better support transparency, medical research and innovation?
Watch this video translated in all EU languages! #ClinicalTrials
https://consent.youtube.com/ml?continue=https://www.youtube.com/playlist?list%3DPL7K5dNgKnawakh8SgoURKXojuKoyc387Z%26cbrd%3D1&gl=FI&hl=fi&pc=yt&uxe=eomcy4&src=1
EU Medicines Agency
Ευρωπαϊκή Επιτροπή 🇪🇺
EU Health - #HealthUnion